Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study.

Critical care (London, England)

Volumn 9, Issue 5, 2005, Pages

  Jochberger, Stefan ^a   Mayr, Viktoria ^a   Luckner, Günter ^a   Fries, Dietmar R ^a   Mayr, Andreas J ^a   Friesenecker, Barbara E ^a   Lorenz, Ingo ^a   Hasibeder, Walter R ^a   Ulmer, Hanno ^a   Schobersberger, Wolfgang ^a   Dünser, Martin W ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; CERTOPARIN; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDEMIOLOGIC METHODS; FACTOR XA; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VENOUS THROMBOSIS;

EID: 33747589676     PISSN: None     EISSN: 1466609X     Source Type: Journal    
DOI: None     Document Type: Article

References (0)